Abdominal Imaging

, Volume 40, Issue 6, pp 1512–1519 | Cite as

Quantification of liver, pancreas, kidney, and vertebral body MRI-PDFF in non-alcoholic fatty liver disease

  • Ilkay S. Idilman
  • Ali Tuzun
  • Berna Savas
  • Atilla Halil Elhan
  • Azim Celik
  • Ramazan Idilman
  • Musturay KarcaaltincabaEmail author



The purpose of the present study was to determine liver, pancreas, kidney, and vertebral fat deposition in NAFLD patients by proton density fat fraction (PDFF) using magnetic resonance imaging (MRI) and to evaluate the relationships among them.


A total of 41 biopsy-proven NAFLD patients underwent MRI-PDFF with IDEAL-IQ. MRI protocol included T1-independent volumetric multi-echo gradient-echo imaging with T2* correction and spectral fat modeling. The MR examinations were performed on a 1.5 HDx MRI system. MRI-PDFF measurements were obtained from liver, pancreas, renal cortex and sinus, and vertebral body. Liver biopsy specimens were retrieved from the archives and evaluated by one pathologist according to NASH CRN.


The median age of the patients was 47 years. The median interval between liver biopsy and MRI examination was 16 days. Mean liver, pancreas, renal cortex, renal sinus, T12 and L1 vertebral body MRI-PDFFs were 18.7%, 5.7%, 1.7%, 51%, 43.2%, and 43.5%, respectively. No correlation between either liver MRI-PDFF or histological steatosis, and other organ MRI-PDFFs was observed. A good correlation between pancreas and vertebral body MRI-PDFFs, and pancreas and renal sinus MRI-PDFFs was observed. Diabetic patients had higher average pancreas MRI-PDFF compared to non-diabetics (12.2%, vs., 4.8%; P = 0.028).


Pancreas and vertebral body MRI-PDFF is well correlated in NAFLD patients and both of them are higher in diabetic patients which may explain increased bone fractures in diabetics. MRI-PDFF can be used to demonstrate fat fractions of different organs and tissues and to understand fat metabolism.


Non-alcoholic fatty liver disease MRI-PDFF Pancreas Kidney Vertebral body 



Musturay Karcaaltincaba has been supported by the Turkish Academy of Sciences (TUBA), in the framework of the Young Scientist Award Program (EA-TUBA-GEBIP/2011). Ramazan Idilman is an associate member of the TUBA.

Conflict of interest

None of the authors have relevant conflicts of interest to disclose.


  1. 1.
    Angulo P (2002) Nonalcoholic fatty liver disease. N Engl J Med 346:1221–1231PubMedCrossRefGoogle Scholar
  2. 2.
    Neuschwander-Tetri BA, Caldwell SH (2003) Nonalcoholic steatohepatitis: summary of an AASLD single topic conference. Hepatology 37:1202–1219PubMedCrossRefGoogle Scholar
  3. 3.
    Vuppalanchi R, Chalasani N (2009) Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: selected practical issues in their evaluation and management. Hepatology 49:306–317PubMedCentralPubMedCrossRefGoogle Scholar
  4. 4.
    Lewis JR, Mohanty SR (2010) Nonalcoholic fatty liver disease: a review and update. Dig Dis Sci 55:560–578PubMedCrossRefGoogle Scholar
  5. 5.
    Bravo A, Sheth S, Chopra S (2001) Liver biopsy. N Engl J Med 344:495–500PubMedCrossRefGoogle Scholar
  6. 6.
    Longo R, Pollesello P, Ricci C, et al. (1995) Proton MR spectroscopy in quantitative in vivo determination of fat content in human liver steatosis. J Magn Reson Imaging 5:281–285PubMedCrossRefGoogle Scholar
  7. 7.
    Szczepaniak LS, Nurenberg P, Leonard D, et al. (2005) Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population. Am J Physiol Endocrinol Metab 288:462–468CrossRefGoogle Scholar
  8. 8.
    Cowin GJ, Jonsson JR, Bauer JD, et al. (2008) Magnetic resonance imaging and spectroscopy for monitoring liver steatosis. J Magn Reson Imaging 28:937–945PubMedCrossRefGoogle Scholar
  9. 9.
    Reeder SB, Cruite I, Hamilton G, Sirlin CB (2011) Quantitative assessment of liver fat with magnetic resonance imaging and spectroscopy. J Magn Reson Imaging 34:729–749PubMedCrossRefGoogle Scholar
  10. 10.
    Reeder SB, Sirlin CB (2010) Quantification of liver fat with magnetic resonance imaging. Magn Reson Imaging Clin N Am 18:337–357PubMedCentralPubMedCrossRefGoogle Scholar
  11. 11.
    Reeder SB, Robson PM, Yu H, et al. (2009) Quantification of hepatic steatosis with MRI: the effects of accurate fat spectral modeling. J Magn Reson Imaging 29:1332–1339PubMedCentralPubMedCrossRefGoogle Scholar
  12. 12.
    Yokoo T, Bydder M, Hamilton G, et al. (2009) Nonalcoholic fatty liver disease: diagnostic fat-grading accuracy of low-flip-angle multiecho gradient-recalled-echo MR imaging at 1.5 T. Radiology 251:67–76PubMedCentralPubMedCrossRefGoogle Scholar
  13. 13.
    Kim H, Taksali SE, Dufour S, et al. (2008) Comparative MR study of hepatic fat quantification using single voxel proton spectroscopy, two point Dixon and three-point IDEAL. Magn Reson Med 59:521–527PubMedCentralPubMedCrossRefGoogle Scholar
  14. 14.
    Permutt Z, Le TA, Peterson MR, et al. (2012) Correlation between liver histology and novel magnetic resonance imaging in adult patients with non-alcoholic fatty liver disease—MRI accurately quantifies hepatic steatosis in NAFLD. Aliment Pharmacol Ther 36:22–29PubMedCentralPubMedCrossRefGoogle Scholar
  15. 15.
    Tang A, Tan J, Sun M, et al. (2013) Nonalcoholic fatty liver disease: MR imaging of liver proton density fat fraction to assess hepatic steatosis. Radiology 267:422–431PubMedCentralPubMedCrossRefGoogle Scholar
  16. 16.
    Idilman IS, Aniktar H, Idilman R, et al. (2013) Hepatic steatosis: quantification by proton density fat fraction with MR imaging versus liver biopsy. Radiology 267:767–775PubMedCrossRefGoogle Scholar
  17. 17.
    Patel NS, Peterson MR, Brenner DA, et al. (2013) Association between novel MRI-estimated pancreatic fat and liver histology-determined steatosis and fibrosis in non-alcoholic fatty liver disease. Aliment Pharmacol Ther. 37:630–639PubMedCentralPubMedCrossRefGoogle Scholar
  18. 18.
    Patel NS, Peterson MR, Lin GY, et al. (2013) Insulin resistance increases MRI-estimated pancreatic fat in nonalcoholic fatty liver disease and normal controls. Gastroenterol Res Pract. doi: 10.1155/2013/498296 PubMedCentralPubMedGoogle Scholar
  19. 19.
    Kleiner DE, Brunt EM, Van Natta ML, et al. (2005) Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41:1313–1321PubMedCrossRefGoogle Scholar
  20. 20.
    World Health Organization (1999) Report of a WHO consultation: definition of metabolic syndrome in definition, diagnosis and classification of diabetes mellitus. Geneva: World Health organization, Department of Noncommunicable Disease SurveillanceGoogle Scholar
  21. 21.
    Matthews DR, Hosker JP, Rudenski AS, et al. (1985) Homeostasis model assessment: insulin resistance and beta cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412–419PubMedCrossRefGoogle Scholar
  22. 22.
    Schwenzer NF, Machann J, Martirosian P, et al. (2008) Quantification of pancreatic lipomatosis and liver steatosis by MRI: comparison of in/opposed-phase and spectral-spatial excitation techniques. Invest Radiol 43:330–337PubMedCrossRefGoogle Scholar
  23. 23.
    Sijens PE, Edens MA, Bakker SJ, Stolk RP (2010) MRI-determined fat content of human liver, pancreas and kidney. World J Gastroenterol 16:1558–1559PubMedCentralPubMedCrossRefGoogle Scholar
  24. 24.
    Tushuizen ME, Bunck MC, Pouwels PJ, et al. (2007) Pancreatic fat content and beta-cell function in men with and without type 2 diabetes. Diabetes Care 30:2916–2921PubMedCrossRefGoogle Scholar
  25. 25.
    Kim SY, Kim H, Cho JY, et al. (2014) Quantitative assessment of pancreatic fat using unenhanced CT: pathologic correlation and clinical implications. Radiology 271:104–112PubMedCrossRefGoogle Scholar
  26. 26.
    Chunghtai HL, Morgan TM, Rocco M, et al. (2010) Renal sinus fat and poor blood pressure control in middle aged and elderly individuals at risk for cardiovascular events. Hypertension 56:901–906CrossRefGoogle Scholar
  27. 27.
    Foster MC, Hwang SJ, Poster SA, et al. (2011) Fatty kidney, hypertension, and chronic kidney disease: the Framingham Heart Study. Hypertension 58:784–790PubMedCentralPubMedCrossRefGoogle Scholar
  28. 28.
    Shen W, Chen J, Punyanitya M, et al. (2007) MRI-measured bone marrow adipose tissue is inversely related to DXA-measured bone mineral in Caucasian women. Osteoporos Int 18:641–647PubMedCentralPubMedCrossRefGoogle Scholar
  29. 29.
    Shen W, Scherzer R, Gantz M, et al. (2012) Relationship between MRI-measured bone marrow adipose tissue and hip and spine bone mineral density in African-American and Caucasian participants: the CARDIA study. J Clin Endocrinol Metab 97:1337–1346PubMedCentralPubMedCrossRefGoogle Scholar
  30. 30.
    Bredella MA, Gill CM, Gerweck AV, et al. (2013) Ectopic and serum lipid levels are positively associated with bone marrow fat in obesity. Radiology. 269:534–541PubMedCentralPubMedCrossRefGoogle Scholar
  31. 31.
    Ergen FB, Gulal G, Yildiz AE, et al. (2013) Fat fraction estimation of the vertebrae in females using the T2*-IDEAL technique in detection of reduced bone mineralization level: comparison with bone mineral densitometry. J Comput Assist Tomogr 38:320–324CrossRefGoogle Scholar
  32. 32.
    Pirgon O, Bilgin H, Tolu I, et al. (2011) Correlation of insulin sensitivity with bone mineral status in obese adolescents with nonalcoholic fatty liver disease. Clin Endocrinol (Oxf) 75:189–195CrossRefGoogle Scholar
  33. 33.
    Campos RM, de Piano A, da Silva PL, et al. (2012) The role of pro/anti-inflammatory adipokines on bone metabolism in NAFLD obese adolescents: effects of long-term interdisciplinary therapy. Endocrine 42:146–156PubMedCrossRefGoogle Scholar
  34. 34.
    Pardee PE, Dunn W, Schwimmer JB (2012) Non-alcoholic fatty liver disease is associated with low bone mineral density in obese children. Aliment Pharmacol Ther. 35:248–254PubMedCrossRefGoogle Scholar
  35. 35.
    Moon SS, Lee YS, Kim SW (2012) Association of nonalcoholic fatty liver disease with low bone mass in postmenopausal women. Endocrine 42:423–429PubMedCrossRefGoogle Scholar
  36. 36.
    Karampinos DC, Melkus G, Baum T, et al. (2013) Bone marrow fat quantification in the presence of trabecular bone: initial comparison between water-fat imaging and single-voxel MRS. Magn Reson Med. doi: 10.1002/mrm.24775 PubMedCentralPubMedGoogle Scholar
  37. 37.
    Gee CS, Nguyen JT, Marquez CJ, et al. (2014) Validation of bone marrow fat quantification in the presence of trabecular bone using MRI. J Magn Reson Imaging. doi: 10.1002/jmri.24795 PubMedGoogle Scholar
  38. 38.
    Cornish J, Callon KE, Bava U, et al. (2001) Effects of calcitonin, amylin and calcitonin gene-related peptide on osteoclast development. Bone 29:162–168PubMedCrossRefGoogle Scholar
  39. 39.
    Ahmed LA, Joakimsen RM, Berntsen GK, Fonnebo V, Schirmer H (2006) Diabetes mellitus and the risk of non-vertebral fractures: the Tromso study. Osteoporos Int 17:495–500PubMedCrossRefGoogle Scholar
  40. 40.
    Strotmeyer ES, Cauley JA, Schwartz AV, et al. (2005) Nontraumatic fracture risk with diabetes mellitus and impaired fasting glucose in older white and black adults: the health, aging, and body composition study. Arch Intern Med 165:1612–1617PubMedCrossRefGoogle Scholar
  41. 41.
    Janghorbani M, Feskanich D, Willett WC, Hu F (2006) Prospective study of diabetes and risk of hip fracture: the Nurses’ Health Study. Diabetes Care 29:1573–1578PubMedCrossRefGoogle Scholar
  42. 42.
    Janghorbani M, Van Dam RM, Willett WC, Hu FB (2007) Systematic review of type 1 and type 2 diabetes mellitus and risk of fracture. Am J Epidemiol 166:495–505PubMedCrossRefGoogle Scholar
  43. 43.
    Patsch JM, Li X, Baum T, et al. (2013) Bone marrow fat composition as a novel imaging biomarker in postmenopausal women with prevalent fragility fractures. J Bone Miner Res 28:1721–1728PubMedCentralPubMedCrossRefGoogle Scholar
  44. 44.
    Baum T, Yap SP, Karampinos DC, et al. (2012) Does vertebral bone marrow fat content correlate with abdominal adipose tissue, lumbar spine bone mineral density, and blood biomarkers in women with type 2 diabetes mellitus? J Magn Reson Imaging 35:117–124PubMedCentralPubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2015

Authors and Affiliations

  • Ilkay S. Idilman
    • 1
  • Ali Tuzun
    • 2
  • Berna Savas
    • 3
  • Atilla Halil Elhan
    • 4
  • Azim Celik
    • 5
  • Ramazan Idilman
    • 2
  • Musturay Karcaaltincaba
    • 1
    Email author
  1. 1.Department of Radiology, Faculty of MedicineHacettepe UniversityAnkaraTurkey
  2. 2.Department of Gastroenterology, Faculty of MedicineAnkara UniversityAnkaraTurkey
  3. 3.Department of Pathology, Faculty of MedicineAnkara UniversityAnkaraTurkey
  4. 4.Department of Biostatistics, Faculty of MedicineAnkara UniversityAnkaraTurkey
  5. 5.General Electric HealthcareIstanbulTurkey

Personalised recommendations